Killestein 2002.
Methods | Cross‐over study (4 week treatment periods) | |
Participants | 16 MS patients | |
Interventions | 2.5‐5mg THC v. C. sativa plant extract v. placebo | |
Outcomes | Ashworth score, EDSS, MS Functional composite score (timed walk, 9 hole peg test, PASAT), MS Fatigue Severity Scale, SF36, visual analogue scales | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Unclear risk | B ‐ Unclear |